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20S core protease consists of four rings of seven subunits each that make a hollow cylinder. The inner two rings consist of β subunits (Groll et al., 1997) . The proteolytic activity is located in the inner cavity of the cylinder and resides in three β subunits of the inner two rings. Each of these subunits has slightly different catalytic activities: β 1 cleaves after acidic residues (caspaselike activity); β 2 after basic residues (trypsin-like activity); and β 5 after hydrophobic residues (chymotrypsin-like activity) (Dick et al., 1998) . Together, these subunits degrade proteins into 3-20 amino acid long peptides that are released into the cytosol or nucleus (Kurepa and Smalle, 2008) .
Crystallographic data revealed that the α ,β-unsaturated amide of SylA is attacked by the N-terminal threonine of the catalytic β subunits, resulting in an irreversible, covalent ether bond (Groll et al., 2008) . Further studies showed that SylA has anti-apoptotic properties in mammalian cells and is therefore a promising novel anti-cancer drug, having different
properties when compared to e.g. bortezomib, a proteasome inhibitor that is currently used in the clinic as an anti-cancer drug (Coleman et al., 2006; Clerc et al., 2009a) .
That SylA inhibits the plant proteasome in vivo has been demonstrated by its ability to promote the accumulation of cyclin-GUS fusion proteins in root tips (Groll et al., 2008) .
Beyond this, little is known on how this small molecule effector interacts with its natural host target and if the proteasome is the only target in plants. Here, we study the action of SylA in plants using activity-based probes, which are reporter-tagged inhibitors that react with active site residues of enzymes in a mechanism-dependent manner. The irreversible covalent bond facilitates the display of labeled enzymes on protein gels, and/or the identification of labeled proteins by affinity capture and mass spectrometry (Cravatt et al., 2008) . We recently introduced proteasome activity profiling in plants using MV151, a fluorescent vinyl sulfone probe that labels the β 1, β 2, and β 5 subunits of the proteasome and several papain-like cysteine proteases (PLCPs) (Gu et al., 2010) .
Activity-based Protein Profiling (ABPP) is a simple and robust approach that is now also used in plant science (Kolodziejek & Van der Hoorn 2010) . In this study, we further developed the ABPP technology to facilitate detailed studies of the selectivity of SylA on its natural host target, the plant proteasome. To this end, we introduce novel, selective proteasome probes and established procedures for in vivo proteasome activity profiling and imaging. With these tools, and using SylA derivatives, we examined the subunit selectivity and subcellular targeting of SylA in living plant cells.
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RESULTS

Comparison of three proteasome probes in vitro
In this study we used three different probes that target the proteasome ( Figure 1A and Supplemental Figure S1 ). All three probes carry a fluorescent reporter tag but differ in their reactive group. MV151 contains a vinyl sulfone (VS), and has previously been used to investigate plant and animal proteasomes (Verdoes et al., 2006; Gu et al., 2010) . MVB003 is based on the highly selective proteasome inhibitor epoxomicin and carries an epoxyketone reactive group (Meng et al., 1999) . RhSylA is a fluorescent SylA derivative, previously used on animal extracts (Clerc et al., 2009a) , carrying a reactive Michael system in the ring structure.
Each of these reactive groups binds covalently and irreversibly with the N-terminal active site threonine of the catalytic subunits of the proteasome, but through distinct molecular mechanisms (Groll et al., 2008; Huang and Chen, 2009 ). In addition to MVB003, we used two more epoxomicin-based probes, which only differ from MVB003 in the reporter tags. MVB070 contains bodipy carrying an azide minitag for click chemistry, and MVB072 contains bodipy carrying a biotin for affinity purification (Supplemental Figure S1 ). MVB003, MVB070 and MVB072 cause nearly identical labeling profiles (data not shown), but only MVB003 was used for in vivo experiments.
To determine in vitro labeling with the probes, extracts from Arabidopsis cell cultures were incubated with the probes for two hours. Proteins were separated on protein gels and To investigate the potential subunit selectivity of the different probes, we performed time course labeling experiments in vitro. Labeling in extracts occurs within minutes for all three probes ( Figure 1C ). MV151 and MVB003 label β 5 within one minute, followed quickly by β 2, whereas β 1 becomes labeled within 15 minutes (for MVB003) or 30 minutes (for MV151) ( Figure 1C ). In contrast, RhSylA labels β 2 and β 5 simultaneously within minutes, but β 1 labeling takes one hour, which is longer when compared to MV151 and MVB003 labeling ( Figure 1C ). These data show that MV151 and MVB003 preferentially target β 5, whereas
RhSylA preferentially targets β 5 and β 2. Figure 1E ).
Taken together, these experiments demonstrate that SylA and RhSylA preferentially target β 2 and β 5 subunits of the proteasome.
Comparison of three proteasome probes in vivo
To establish in vivo labeling in Arabidopsis cell cultures, the toxicity of the probes and inhibitors was first determined using Evans blue staining (Kaffarnik et al., 2008) . amino acids (bold in Figure 3D ). These data confirm that the epoxomicin-based probes preferentially label the β 5 proteasome catalytic subunit in vivo.
Concentrations of 100
Structure-activity relationships of SylA derivatives
SylA Figure 5J) . Notably, significant amounts of free, unreacted probe were found in the frontier of the protein gel ( Figure 5J ), indicating that some of the free probe stayed inside the cells after washing. However, since free probe is also present in the absence of nuclear fluorescence ( Figure 5H and lane 3 in Figure 5J ), the free probe is probably distributed throughout the cells. In conclusion, these data show that RhSylA accumulates in the nucleus. That nuclear accumulation can be prevented by adding and excess SylA before, but not during the labeling, indicates that nuclear RhSylA accumulation is irreversible.
SylA labels both the nuclear and cytoplasmic proteasome
To verify the subcellular targeting biochemically, subcellular fractionation experiments were performed. We labeled cell cultures with and without MVB003 and RhSylA and generated nuclei-enriched (NE) and nuclei-depleted (ND) fractions. Subcellular markers PEPC for cytoplasmic proteins and histone H3 for nuclear proteins confirmed that the fractions were not cross-contaminated ( Figure 6A ). both the ND and NE fraction and the relative signals indicate that only 5% of the cellular proteasomes are localized in the nucleus, given the fact that the NE fraction was 10x concentrated compared to the ND fraction ( Figure 6A) . Importantly, treatment with MVB003 or RhSylA does not affect the PBA1 levels in the different compartments, indicating that these probes do not influence the subcellular distribution of the proteasome. Analysis of fluorescently labeled proteins reveals that RhSylA labels both β 2 and β 5 subunits in the nucleus and the cytoplasm, but the signals in the nucleus are relatively stronger ( Figure 6A, lanes 5 and 6) .
Surprisingly, also MVB003 causes relatively strong labeling of the nuclear proteasome ( Figure   6A , lane 3), which is in contrast to the strong fluorescence of MVB003 in the cytoplasm (Figure 5 ).
To investigate if SylA itself targets the nuclear proteasome, we took advantage of the fact that covalent labeling of the β 1 subunit causes a shift on the western with anti-PBA1
antibody (Gu et al., 2010) . To maximize β 1 labeling with SylA, we incubated cell cultures with 50 and 100 μ M SylA. Even though the difference in molecular weight (MW) is small, the SylA-β 1 conjugate is clearly separated from the unreacted β 1 since a signal with a slightly higher MW appears in total extracts (T) of SylA-treated cells ( Figure 6B, lanes 1-3) . Subcellular fractionation of this sample into a nuclei-depeleted (ND) and nuclei-enriched (NE) fraction
showed that the SylA-β1 conjugates occur in both the cytoplasmic and nuclear fractions ( Figure   6B , lanes 4-9). The ratio of the SylA-β1 when compared to the unreacted β 1 is similar between the nuclear and cytoplasmic fractions, indicating that SylA labels the proteasome in both the cytoplasm and nucleus.
DISCUSSION
Through a thorough characterization of in vivo and in vitro profiling and imaging with three unrelated proteasome probes, we have established new procedures for proteasome studies and determined the subunit and subcellular specificity of proteasome inhibitor SylA, a bacterial small molecule effector released by some P. syringae strains during infection.
SylA targets β 2 and β 5 catalytic subunits of the plant proteasome
We found that SylA preferentially targets only two of the three catalytic subunits of the plant proteasome. RhSylA preferentially labels the β 2 and β 5 subunits in vitro during short labeling times and at low RhSylA concentrations (Figures 1C and 1D) . The same subunit selectivity by
RhSylA was observed in vivo ( Figures 2C, 2D and 6A) Figure 1E ) and in vivo ( Figure 2D ). The subunit selectivity is different from that of MV151 and MVB003 which preferentially label β 5. β 1 labeling is slow for all probes, though β 1 is best labeled by MVB003 or MV151 ( Figure 1C) .
The subunit selectivity of SylA was also observed with studies on the yeast proteasome (Groll et al., 2008) and can be explained using the crystal structure of the yeast proteasome inhibited by SylA (Groll et al. 2008 , PDB code 2ZCY). The crystal structure of the 20S yeast proteasome contains six SylA molecules, three on each of the two middle rings of β subunits ( Figure 7A) . SylA is covalently bound to the N-terminal threonine of β 1, β 2 and β 5, and the dipeptide tail of SylA also interacts with the adjacent subunit ( Figure 7B ). The structure of the adjacent subunits has important implications on how SylA can bind to each of the three binding pockets. Overlay of the SylA structures shows that the dipeptide tail of SylA is pushed downwards when bound to the β 1 subunits but not when bound to the β 2 and β 5 subunits ( Figure 7C ). This is caused by a bulky H116 side chain in the subunit adjacent to the β 1 subunit that makes the β 1 binding pocket smaller when compared to that of the β 2 and β 5 subunits (Figures 7D-F) . Consequently, SylA bound to the β 1 binding pocket is unable to make a hydrogen bond with D114 of the adjacent subunit, which is an important interaction of SylA bound to the binding pocket of β 2 and β 5 (Figures 7D-F) . The presence of the D114 interaction in β 2 and β 5 binding pockets explains why SylA preferentially targets the β 2 and β 5 subunits.
Since many properties including H116 and D114 are conserved in the proteasome subunits of Arabidopsis, it seems likely that this interpretation from the yeast crystal structure might also apply for the Arabidopsis proteasome.
We found that the conformation of the valine at position 1 of the dipeptide tail of SylA contributes to the specificity for the β 2 subunit since the SylA derivatives carrying a D-Val at this position have a reduced affinity for β 2 ( Figure 4B ). Also this observation can be explained using the crystal structure of the yeast proteasome bound to SylA (Figure 7) . 
Nuclear accumulation of SylA
Unexpectedly, imaging experiments show that SylA and RhSylA accumulate in the nucleus.
MVB003 causes fluorescence in both the nucleus and cytoplasm, but preincubation with SylA suppresses mostly the nuclear fluorescence, in contrast to preincubation with epoxomicin, which suppresses fluorescence in both compartments (Figure 5A-E) . Furthermore, RhSylA causes mostly nuclear fluorescence ( Figure 5F ). The fact that RhSylA-sat does not accumulate in the nucleus ( Figure 5G ) and that nuclear fluorescence by RhSylA labeling is not washed out ( Figure 5F ) or suppressed by adding an excess SylA after RhSylA labeling indicates that
RhSylA is immobilized in the nucleus. However, subcellular fractionation studies could not confirm that SylA preferentially labels the nuclear proteasome (Figure 6 ). There can be many explanations for this apparent discrepancy. One explanation might be that the protocol for subcellular fractionation does not exclude ex vivo labeling because SDS would disintegrate the nuclear compartment before separation. Free, unreacted probes that accumulates in the cells and remain after washing (Figure 5J ), might react ex vivo with the proteasome in both the cytoplasmic and nuclear fractions, hiding signals caused by in vivo labeling. However, nuclear fractionations in the presence of proteasome inhibitor MG132 did not reduce labeling of the nuclear proteasome by MVB003 ( Figure S3 ). Another explanation might be that when used at high SylA concentrations, proteasome labeling occurs also in the cytoplasm.
Several mechanistic explanations for potential nuclear targeting of SylA can be excluded by the current dataset. One possibility is that SylA is transported to the nucleus and reacts more efficiently with the nuclear proteasome because the SylA concentration is higher in the nucleus. This would imply that SylA is a cargo for the nuclear import machinery. However, we can rule out the possibility that free SylA concentrates in the nucleus since nuclear fluorescence by MVB003 or RhSylA is competable by preincubation with SylA but not the inactive SylA-sat derivative ( Figure 5 ). It might be that SylA blocks nuclear import at high concentrations, preventing probes from entering the nucleus. However, SylA was found to react with the nuclear proteasome using subcellular fractionation experiments. A third explanation is that SylA-labeled proteasomes move from the cytoplasm to the nucleus. However, although nuclear import of proteasomes from the cytoplasm is regulated and proteasome inhibition may However, such difference in subcellular fluorescence has not been described for these fluorophores before, and we found that also untagged SylA suppresses nuclear fluorescence of MVB003 labeling. A fifth possibility is that the proteasome in the nucleus is more active when compared to the proteasome in the cytoplasm. This would be consistent with the strong labeling of the nuclear proteasome by both MVB003 and RhSylA ( Figure 6B) . A sixth mechanism for nuclear targeting may be that SylA has a higher affinity for the nuclear proteasome, e.g. mediated by a different composition of the proteasome. Although a different composition of the nuclear proteasome has not yet been described yet, compositions and functions of proteasomes may differ. The immunoproteasome described in animals, for example, appears during immune responses and contains different catalytic subunits that are responsible for the release of more hydrophobic peptides that are used for antigen display (Rock et al., 1994; Goldberg et al., 2002) . Differences in proteasome compositions and possible subcellular targeting by SylA are an interesting topic for future studies.
Nuclear accumulation of SylA may have important biological implications. The proteasome degrades a series of nucleus-specific proteins, such as transcriptional regulators. For example, the proteasome degrades nuclear proteins NPR1, EIN2, and JAZ, which are important components of the signaling cascades of the stress hormones salicylic acid, ethylene and jasmonate, respectively (Spoel et al., 2009; Qiao et al., 2009; Thines et al., 2007; Chini et al., 2007) . SylA might be produced to interfere in these pathways. Indeed, we found that SylA promotes bacterial growth during SA-induced immunity (Misas-Villamil, Kolodziejek and Van der Hoorn, unpublished results). Interfering with nuclear but not cytoplasmic proteasome activities might therefore be beneficial for Pseudomonas syringae producing SylA.
New tools for in vivo proteasome activity profiling and imaging
During our studies on SylA targeting we made important technological advances to study the proteasome in vivo. Toxicity of the probes during in vivo labeling was found to be at acceptable low levels when low probe concentrations and relatively short labeling times are used, probably because these probes only label a fraction of the active proteasomes. We showed that the epoxyketone-based MVB003 and the syrbactin-based RhSylA are highly specific proteasome probes, whereas the vinyl-sulfone based MV151 also labels papain-like cysteine proteases, especially in vivo (Gu et al., 2010) . These characteristics have important implications for the use www.plantphysiol.org on January 22, 2018 -Published by Downloaded from Copyright © 2010 American Society of Plant Biologists. All rights reserved.
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of these probes in vivo. MV151 has the advantage that it displays both proteasome and protease activities in activity profiles, allowing simultaneous monitoring of both proteolytic machinery. This revealed, for example, that the frequently used proteasome inhibitor MG132 preferentially targets PLCPs when used in vivo (Kaschani et al., 2009) , which has important implications for the conclusions from studies where protein degradation was studied using MG132. In contrast to in vivo proteasome activity profiling, imaging of proteasome labeling, however, should preferentially be done using MVB003 or RhSylA, since these probes do not label PLCPs. In addition, we found that the labeling of the different subunits depends on the probes used and on timing and probe concentration. Furthermore, we found that proteasome labeling occurs within minutes in vitro and in vivo. Therefore, special care had to be taken to prevent ex vivo labeling during extraction of in vivo labeled materials. Quick in vivo labeling indicates that there is an efficient uptake of these probes through the cell membrane. Thus, our study introduces the parameters and probes to study the proteasome in vivo.
MATERIALS AND METHODS
Chemicals
E-64d and epoxomicin were from Sigma and BioMol, respectively. Synthesis of MV151, SylA, Rh-SylA and other SylA derivatives has been described previously (Verdoes et al., 2006; Clerc et al., 2009a; 2009b , 2010a , 2010b . Synthesis of MVB003, MVB070 and MVB072 have been described in the supplemental document. Aliquots of the probes and inhibitors are available upon request.
Plant materials
Arabidopsis thaliana ecotype Columbia plants were grown in a growth chamber at 24 °C concentrated than the NE and T fractions. Proteins were separated on protein gels and detected by fluorescent scanning and using antibodies for PBA1, PEPC and Histone, as previously described (Noel et al., 2007; Chang et al., 2009) .
Activity-based imaging
The fluorescence of RhSylA (rhodamine ex543/em570), MVB003 (Bodipy ex532/em580), and Heuchst3342 (ex350/em450) was detected by Carl Zeiss LSM 510 confocal microscope.
Confocal microscopy was performed with HeNe1 (ex534) laser and the UV laser, respectively.
The Zeiss LSM Image Examiner was used for confocal image processing. MVB003 signals were quantified by photometric measurements in situ within 550-600nm ranges. All experiments were done with identical acquisition settings for each probe Arabidopsis cell cultures were preincubated for 30 minutes with DMSO, 50 µM SylA or 10 µM epoxomicin, and labeled for 2 hours with 2 µM MVB003. Cells were washed and imaged by confocal microscopy.
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